(Q53401390)
Statements
Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiol (English)
1 reference
Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol (English)
P. Lammers
1 January 1991
70
6
497-500